-+ 0.00%
-+ 0.00%
-+ 0.00%

ESPERION THERAPEUTICS INC - ALKEM AGREES NOT TO MARKET GENERIC NEXLETOL OR NEXLIZET IN US BEFORE APRIL 19, 2040

Reuters·02/17/2026 13:00:12

Please log in to view news